According to the vaccine's maker, Valneva, the FDA based its decision to suspend the shot on four new serious adverse events ...

By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is ...

The United States Food and Drug Administration (FDA) has suspended the license for Valneva's chikungunya vaccine Ixchiq with ...

The FDA suspends Ixchiq, the only approved chikungunya vaccine, over safety concerns, impacting its availability in the U.S.

Valneva must immediately cease U.S. shipments and sales of Ixchiq, a vaccine for chikungunya virus. The FDA recently lifted a ...

The claim stemmed from a Daily Beast report that cited Dr. Aseem Malhotra, a British cardiologist and associate of the health ...

The agency said it had become aware of more reports of serious adverse events, leading center director Vinay Prasad to ...

Hey, good morning. Today, we see CBER suspend the license for a chikungunya vaccine, look at a push to recall a safety and ...

Thinking about what to do with your Pfizer shares? You are definitely not alone, especially as sentiment around the stock ...

Last week, the American Academy of Pediatrics released its own vaccine recommendations that differed from the federal ...

Those with private health insurance expected to have an easier time getting vaccines than those on Medi-Cal if CDC changes ...

Shares of French drugmaker Valneva slumped more than 20% on Monday after the U.S. Food and Drug Administration suspended the ...